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Introduction
Hypothalamic-pituitary lesions present with a variety of
manifestations, including pituitary hormone hypersecretion or
hypo-secretion, sellar enlargement and visual loss. Among
them, pituitary tumours are the most common intracranial
neoplasm accounting for 10.7% of primary central nervous
system tumours. They are classified by size (microadenomas <
10 mm and macroadenomas > 10 mm) and according to their
ability to produce hormones (functioning or nonfunctioning
adenomas). Prevalence studies suggest pituitary adenomas are
common in the normal population and were present in between
1% and 35% of pituitaries studied at autopsy and in 1% to 40%
of patients undergoing an MRI scan for reasons other than to
assess the hypothalamic-pituitary axis. The prevalence of
macroadenomas was estimated to be 0.16% to 0.20%.1
Empty sella, which is also considered a distinct lesion of
pituitary gland, occurs when the subarachnoid space extends
into the sella turcica, partially filling it with cerebrospinal fluid.
This process causes remodeling and enlargement of the sella
turcica and flattening of the pituitary gland. The presence of an
empty sella does not exclude the possibility of a coexisting
pituitary tumours.2
Existing epidemiological data suggest that the incidence
of pituitary adenomas is rising, although it is difficult to
determine whether this is due to widespread access to magnetic
resonance imaging (MRI) and accurate biochemical testing,
leading to improved recognition of clinically relevant pituitary
tumours.3
The true prevalence of pituitary lesions in our region is
conflicting and discordant. To date, there is no local experience
of etiology and endocrinal status of patients with pituitary
lesions therefore, current study is designed with the aim to
describe the etiology, functional status and short term outcome
of patients with pituitary lesions, presented to a single tertiary
care center in Pakistan.
Materials and Methods
This study was done in the Aga Khan University
Hospital (AKUH), Karachi Pakistan, over the period of 2000 to
2007. During this time period, 9000 gadolinum enhanced MRIs
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Abstract
Objective: To describe the etiology, functional status and short term outcome of patients with pituitary lesions (PL). 
Methods: Brain or pituitary MRI reports of 3,753 patients were analyzed for PL over the period of 2000 to 2007,
done at the Aga Khan University Hospital (AKUH), Karachi, Pakistan. MRIs with reported PL and all those
ordered by Endocrinologists with or without pituitary abnormalities, were included in the analysis. This made a
total of 338 (9%) MRI reports. PL were defined as pituitary tumors, cysts, haemorrhage, hypoplasia; and empty
sella. Patients with these PL, were analyzed for symptoms, hormonal profile and short term outcome in the
hospital retrospectively. 
Results: In the analysis of 338 MRI reports, 23% had normal pituitary gland on MRI examination.
Hypogonadotrophic hypogonadism was the commonest (38.5%) endocrine abnormality seen with normal
pituitary MRI, followed by hypopituitarism (5.1%). Most common PL identified were macroadenoma (38.7%),
empty sella (16.5%) and microadenoma (12.7%). Patients with macroadenoma had 58% of non-functional
tumours while 19.1% had hypopituitrism, 17.6% had acromegaly and 17.5% had prolactinoma. Majority of these
lesions were causing headache and visual symptoms (42.7%) and were treated with surgery (75.5%). Patients
with microadenoma included 39.5% prolactinomas, 18.6% cushing disease, 14% acromegaly, 4.7%
hypogonadotrophic hypogonadism and 2.3% hypopituitrism. Majority of these lesions were treated with drugs
and 37.3% were treated with surgery. In empty sella patients, 32% patients had endocrine abnormalities among
which 21.4% had hypopituitrism, 2% had hypogonadotrophic hypogonadism, and only 6% patients had normal
endocrine workup. A significant number of patients (62.5%) never had endocrine hormonal checkup. 
Conclusion: Although PL are less common entities (9% in 3,753 reports) but they are associated with significant
endocrinal abnormalities and need prompt treatment. Empty sella, which is not considered as a distinct
abnormality, is also associated with significant endocrine deficiencies (JPMA 59:839; 2009).
of brain including pituitary were performed in the Radiology
department of the AKUH. Each MRI was read by an
experienced consultant Radiologist and report was saved in
hospital computer database. We obtained the list of these MRI
reports and analyzed 3,753 MRIs ordered by Endocrinologists
(367), Neurologists (2379), Neurosurgeons (910) and
Ophthalmologists (95). 
MRIs with reported pituitary lesions and all those
ordered by Endocrinologists with or without pituitary
abnormalities, were included in the analysis. This made a total
of 338 (9%) MRI reports available for review.
Pituitary Lesions reported on brain or pituitary MRIs,
were defined as pituitary tumours (pituitary microadenoma
when size < 1 cm; pituitary macroadenoma when size > 1 cm),
cysts, haemorrhage, hypoplasia; and empty sella. Empty sella
was diagnosed when there was absence of pituitary gland on the
radiographic image (MRI). Patient charts were reviewed and
necessary information regarding demographics, hormonal
profile and outcome was collected. Short term outcome was
taken as initial treatment patient was given in the hospital before
discharge.
Functioning pituitary tumours represented tumours
which secrete one or more hormones from the pituitary gland
resulting in the symptoms and signs of the hormone excess.
Non-functioning pituitary lesions represented tumours which
do not secrete any hormone and sometimes can cause inhibition
of the hormones secreted by the pituitary gland, due to the mass
effect.
All laboratory values were interpreted based on the
reporting laboratory's normal range, unless stated otherwise.
Hormonal assays were done using standard radio-immunoassay
methods. Acromegaly was diagnosed on the basis of clinical
features and high IGF-1 and positive Oral glucose tolerance test
with growth hormone. Cushing's disease was diagnosed when
there was high ACTH and inappropriate suppression of cortisol
(> 50%) on high dose dexamethasone suppression tests.
Hyperprolactinaemia was defined as prolactin (PRL) elevation
(upper limits of normal ranged from 22 µg/L depending on
laboratory). Hypogonadotropic hypogonadism was diagnosed
when estradiol or testosterone levels were low in the presence
of inappropriately normal or low FSH and/or LH levels.
Hypopituitarism included deficiency of the GH (evoked GH <3
ng/mL), gonadal (FSH/LH), thyroid (abnormal thyroid
hormone levels with inappropriate TSH levels), adrenal
(blunted cortrosyn responses) axes, and/or panhypopituitarism.
Thyrotropinoma (secondary hyperthyroidism) was diagnosed
when there was thyrotoxicosis with inappropriately normal
TSH. Diabetes insipidus was diagnosed on the basis of clinical
features with high serum osmolality and low urine osmolality
and response to desmopressin. Isolated Growth hormone
deficiency was diagnosed using measurement of low IGF-1
(with respect to age and gender) and Insulin tolerance test with
growth hormone (with peak response of growth hormone less
than 10 ng/dl in hypoglycaemia), in the presence of normal
hormonal profile.
Results
In the analysis of 338 MRI reports, Figure shows the
MRI details of different pituitary lesions found. There were
23% reports who had normal pituitary, and endocrinal
840 J Pak Med Assoc
Table-1: Characteristics of patients with normal and
3 common pituitary lesions.
Normal Pituitary (n = 78, 23%)
Age (mean, years) : Range in years 31.1±14.1 : (12 – 74)
Males / Females 35 (45%) / 43 (55%)
Endocrinal abnormalities
None * 9 (11.5%)
Hypogonadotrophic Hypogonadism 30 (38.5%)
Hypopituitarism 4 (5.1%)
Hyper-prolactinemia 17 (21.8%)
Cushing’s Syndrome 2 (2.6%)
Secondary Hypothyroidism 2 (2.6%)
Isolated Growth hormone deficiency 2 (2.6%)
Not Known 9 (11.5%)
Pituitary Macroadenoma (n = 131, 38.7%)
Age (mean, years) : Range in years 44.36±16.54 : (12 – 84)
Males / Females 64.9% / 35.1%




Not known 14 (10.7%)
Prolactinoma 25 (19.1%)
Acromegaly 23 (17.6%)
Cushing’s Disease 1 (0.8%)
Thyrotropinoma 2 (1.5%)
Hypogonadotrophic Hypogonadism 2 (1.5%)
Diabetes Insipidus (post-operative) 5 (3.8%)
Pituitary Microadenoma (n = 43, 12.7%)
Age (mean, years) : Range in years 34.12±13.5 : (14 – 66)
Males / Females 32.6% / 67.4%





Cushing's Disease 8 (18.6%)
Pan-hypopituitarism 1 (2.3%)
Unknown 6 (14%)
Hypogonadotrophic Hypogonadism 2 (4.7%)
Empty Sella (n = 56, 16.5%)
Age (mean, years) : Range in years 55.63±14.82 : (12 –
78)
Males / Females 28.6% / 71.4%
Endocrinal abnormalities
Not investigated 35 (62.5%)
Hypopituitarism 12 (21.4%)
None 3 (5.4%)
Hypogonadotrophic Hypogonadism 2 (3.6%)
Growth Hormone deficiency 1 (1.8%)
Other Endocrinal Abnormalities 3 (5.4%)
evaluation of these patients revealed 38.5% had
hypogonadotrophic hypogonadism, 5.1% had hypopituitrism
and 2.6% had isolated growth hormone deficiency. The major
pituitary lesion found was Pituitary Macroadenoma (38.7%).
We divided the patients with pituitary lesions into a) Pituitary
Macroadenoma, b) Pituitary Microadenoma and c) Empty
Sella. Details of these lesions are given in Table-1. Table-2
shows various hormonal abnormalities associated with
common pituitary lesions of our study.
Pituitary Macroadenoma (n = 131):
In the patients with these lesions, males predominate,
with a male to female ratio of ratio of 1.8:1. Etiology of these
lesions is given in Table-1 and 2. 
Majority of the patients had non-functional pituitary
tumours (NFPT) (65%, n=86) resulted in endocrinal
disturbances in 48% (n=42) of cases. Table-3 shows different
characterisitics of non-functioning tumours. Visual symptoms
along with headache (42.7%) were the predominant presenting
symptoms of these patients other than symptoms related to
hormonal hyposecretion. Regarding treatment, trans-sphenoidal
pituitary surgery was done in 99 (75.5%) patients, 10 (7%)
patients were referred for radiotherapy after surgery, 5 (3%)
patients were put on hormone replacement therapy and patients
with Prolactinoma were treated with dopamine agonists
(14.3%). 
Patients with NFPT (n=86) had a mean age of 46±15.2
years with male predominance (63% males, 37% females).
Their main presenting symptoms were visual deterioration
(24.4%) and headache (10.5%). Nearly 37.2% had no hormonal
abnormality while 30.2% had hypopituitarism, 2.3% had hyper-
prolactinoma and secondary hypothyroidism.  
Pituitary Microadenoma (n = 43):
The mean age of these patients was 34.12±13.5 years
(Range: 14 - 66) years with male to female ratio of 1:2. Etiology
is given in Table-1 and 2. Symptoms of these patients related to
the type of endocrinal hyper or hyposecretion. None of the
patient had visual symptoms, however headache is present in 7
(16%) cases. Regarding treatment, trans-sphenoidal pituitary
surgery was done in 37.3% of patients, in which 14.2% had
acromegaly and 20% had cushing's disease. Rest of the patients,
of whom majority had prolactinoma, were treated with
dopamine agonists.
Patients with Empty Sella (n=56):
The mean age of patients was 55.63±14.82 (Range: 12-
78) years with male to female ratio of 1:2.5. Etiology is given in
Table 1 and 2. Majority of these patients had brain MRI done
due to other reasons and found to have empty sella. Among
these patients, 37.5% (n=21) had unconsciousness with low
blood pressure, 19.6% (n=11) had headache, 10.7% had
menstrual disorders, weight loss and 7.1% (n=4) had
hyponatraemia. Hormonal abnormalities were found in 32%
patients, while 62.5% patients were not evaluated for hormonal
abnormality. Only 43% patients had consultation from
Endocrinology Department. Patients having hormonal
abnormalities were treated with hormone replacement therapy. 
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Figure: Graph showing frequencies of various pituitary lesions.
Table-2: Endocrinopathies and associated pituitary lesions.
Endocrinal Normal MRI Macro-adenoma Micro-adenoma Empty Sella Cranio-pharyngioma Others 
Abnormality* (n) (%) (%) (%) (%) (%) (%)
None (53) 9 (17) 28 (52.8) 3 (5.7) 3 (5.7) - 10 (18)
Acromegaly (30) - 23 (76.7) 6 (20) - - 1 (3.3)
Cushing's disease (11) 2 (18/2) 1 (9.1) 8 (72.7) - - -
Hyper-prolactinemia (59) 17 (28.8) 25 (42.4) 17 (28.8) - - -
Thyrotropinoma (2) - 2 (100) - - - -
Hypopituitrism (51) 4 (7.8) 25 (49) 1 (2) 12 (23.5) 5 (9.8) 4 (7.9)
Hypogonadotrophic hypogonadism (40) 30 (75) 2 (5) 2 (5) 2 (5) - 4 (10)
Secondary Hypothyroidism (5) 2 (40) 1 (20) - - - 2 (40)
Isolated Growth Hormone deficiency (3) 2 (66.7%) - - 1 (33.3) - -
Secondary Adrenal Insufficiency 1 (20) 2 (40) - 1 (20) 1 (20) -
Not Known (65) 9 (13.8) 14 (21.5) 6 (9.2) 35 (53.8) - -
*Rest of the Endocrinal abnormalities not shown.
Discussion
The present study revealed that 1) Pituitary
macroadenoma were the most common pituitary lesions, 2)
Majority of the macroadenomas were non-functional tumours
(NFPT), 3) In pituitary microadenoma, prolactinoma were the
most common endocrinal abnormality, 4) Patients with Empty
sella syndrome had a significant number of endocrinal
abnormalities, and majority of them were never investigated, 5)
Craniopharyngioma were uncommon tumours in adults, 6)
Visual symptoms were common in patients with
macroadenomas, and 7) Surgery was the common treatment
modality in pituitary macroadenoma. 
Since all MRIs ordered by Endocrinologists were
included in the study, we saw a reasonable number of patients
with normal pituitary MRI report. Most of these patients (75%)
had hypogonadotrophic hypogonadism without any other
hormonal abnormalities. These patients were labeled as having
isolated idiopathic hypogonadotrophic hypogonadism. Our
findings are similar with the previous studies showing that
majority of these patients had normal MRI.4MRI of the brain is
necessary to exclude a pituitary tumours, a prolactinoma or
craniopharyngioma.5 In the absence of a tumours, the cause is
generally thought to be hypothalamic or idiopathic by exclusion. 
Prolactinoma's and non functional pituitary tumours
were the highest pituitary lesions found in our study which is in-
concordance with the previous studies.1,3 In our series,
prolactinoma's in general, were seen more in male patients with
pituitary macroadenomas, while in females, they were more in
microadenomas. This is probably due to the fact that females
present early due to their symptoms of menstrual disorders and
glactorrhea. This finding is also similar to the previous studies
on prolactinomas.6
There are reasonable number of patients with
hypopituitarism (n=51), commonly associated with
macroadenoma (49%), followed by empty sella syndrome
(23.5%) and craniopharyngioma (9.8%). Tomlinson JW et al,7
in their study, showed that non-functinong pituitary tumours
(57%) and craniopharyngioma (12%) were the major causes of
hypopituitarism, while empty sella syndrome contributed 2%.
His findings are somewhat similar to our findings except empty
sella syndrome which contributed significantly in our study. 
Acromegaly is another common functional pituitary
disease seen in our series as well. Majority of these patients had
pituitary macroadenoma. A regional study from an endocrine
referral center, in Srinagar, Kashmir,8 reported highest
frequency of acromegaly in their series, which also reported
more patients with macroadenomas. We also had two cases of
thyrotrophinomas, both had macroadenoma and were treated
with trans-sphenoidal surgery.
Clinically NFPT are the major group in the patients with
macroadenoma (65%) and mostly associated with visual
symptoms, headache and endocrinal dysfunction associated
(48%) with the compression effects on the normal pituitary
gland. This finding is comparable with other studies.9,10 The
endocrinal evaluation given in Table-3, does not show the
associated growth hormone deficiency, because it was not
checked in any case in our series. The multitude of studies
performed on such patients, in recent years shows the potential
benefit of GH therapy in GH-deficient adults suggest that GH
testing should be done in all such patients.11
We saw a significant number of cases (16.5%) who had
empty sella syndrome, found mostly on brain MRIs done for
other reasons. Only one case had secondary empty sella after
surgery, while rest of them had primary empty sella. Primary
empty sella syndrome which results from congenital
incompetence of the diaphragma sellae is common, with an
incidence in autopsy series ranging from 5 to 23%,12 which is
similar to our series as well. Although, endocrine abnormalities
are not a common occurrence in these cases, 32% of our cases
had endocrinal abnormalities. There are several papers and case
reports which showed hormonal abnormalities associated with
empty sella and termed as "empty sella syndrome."12-15 One
large published series of 213 patients of empty sella syndrome
reported prevalence of endocrine dysfunction as 19%.16
Another finding which was related to our series was
predominance of females in such cases.13 Rarely, empty sella
syndrome is also associated with hormone excess possibly due
to coexisting micro-adenoma within the compressed gland,17
although we did not come across such a case in our series. 
Another noteworthy finding in our series is that 62.5%
of patients of empty sella syndrome were not investigated for
any endocrinal abnormality and 43% were sent for
endocrinologist consultation only. The reason could be lack of
unawareness and knowledge regarding the empty sella
syndrome by most of the physicians and surgeons treating such
patients. 
Craniopharyngiomas which are considered a common
sellar tumours in the literature18 especially in childhood
populations and half of the total cases in adults, were not
commonly seen in our study. One of the reason behind is that we
did not include paediatric population in our study, secondly, we
do not have any epidemiological data which supports that
craniopharyngiomas are common sellar tumours in our region as
they are in the western countries. Our later assumption is also
somewhat supported by a regional study reported from Kashmir,
which showed no cases of craniopharyngioma in their study.8
There are several limitations of our study. First of all it
is a retrospective data taken from the patient charts. Secondly,
some of the patients are not evaluated for any endocrine
dysfunction (especially in empty sella cases) at all. Thirdly,
follow-up of the patients was limited.
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Conclusion
To conclude, PL are less common entities in the present
study but they are associated with significant endocrinal
abnormalities and need prompt treatment. Non functional
pituitary macroadenomas causing visual impairement needed
prompt surgery (except prolactinomas in some cases).
Functional pituitary microadenomas also needed surgical
treatment except prolacinomas. Majority of the patients with
hypogonadotrophic hypogonadism have normal pituitary
glands. Empty sella, which is not considered as a distinct
abnormality, is also associated with significant endocrine
deficiencies and it is recommended that all patients with empty
sella should be referred to endocrinologists for assessment.
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